
Leadership in revolutionizing cancer immunotherapy, Garo Armen, Ph.D., Chairman & CEO, Agenus
Synopsis: Garo Armen, Ph.D., is the Chairman and CEO of Agenus, an immuno-oncology company with the goal of treating cancers with novel combinations utilizing its unique portfolio of checkpoint antib...
19 Apr 202327min

Revolutionizing brain health: CNS innovations, AI & more, Craig Thompson, CEO, Cerevance
Synopsis: Craig Thompson is the CEO of Cerevance, a clinical-stage drug discovery and development company focused on developing novel therapeutics for central nervous system diseases. He discusses t...
12 Apr 202323min

Mental health: psychedelics & beyond, Florian Brand, CEO, & Srinivas Rao, CSO, atai Life Sciences
Synopsis: We recorded this episode in December 2022 with Florian Brand and Srinivas Rao, the Co-Founders and CEO & CSO, respectively, of atai Life Sciences, a biopharmaceutical company that leverage...
5 Apr 202333min

High-impact oral small molecule therapy in autoimmune disease, Kevin Judice,Co-Founder & CEO,DICE Tx
Synopsis: Kevin Judice is the Co-Founder and CEO of DICE Therapeutics, a clinical-stage biopharmaceutical company developing transformative medicines for autoimmune and inflammatory diseases. Kevin ...
29 Mar 202328min

A new vision in inflammatory disease: RNAseq led precision medicine, Tariq Kassum, CEO, Celsius Tx
Synopsis: Tariq Kassum, M.D. is the CEO of Celsius Therapeutics, a company pioneering new precision medicines in inflammatory disease by harnessing the power of single-cell RNA sequencing and human ...
22 Mar 202326min

Pioneering therapeutics targeting cellular stress pathways, Prakash Raman, President & CEO, Ribon Tx
Synopsis: Prakash Raman, Ph.D., is the President and CEO of Ribon Therapeutics, a clinical stage biopharmaceutical company pursuing the development of novel small molecules targeting stress support p...
15 Mar 202332min

Novel viral vectors in gene therapy, Joel Schneider, CEO & Robert Kotin, Founder, Carbon Biosciences
Synopsis: Joel Schneider, Ph.D. and Robert Kotin, Ph.D. are the President & CEO and Founder & Chief Technology Advisor, respectively, of Carbon Biosciences, an emerging leader in the development of n...
8 Mar 202326min

Advancing medicines that matter, Matt Gline, CEO, Roivant Sciences
Synopsis: Matt Gline is the CEO of Roivant Sciences, a company that delivers innovative medicines and technologies to patients by building Vants – nimble, entrepreneurial biotech and healthcare techn...
1 Mar 202329min




















